Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale

SIMPLE SUMMARY: Patients with pseudomyxoma peritonei that are not cured by the standard treatment (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy) have no efficacious treatment options. Drugs that inhibit formation of new vessels (anti-angiogenic drugs) could be a therapeutic op...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Yvonne, Fleten, Karianne G., Abrahamsen, Torveig W., Reed, Wenche, Davidson, Ben, Flatmark, Kjersti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201024/
https://www.ncbi.nlm.nih.gov/pubmed/34198773
http://dx.doi.org/10.3390/cancers13112819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201024/
https://www.ncbi.nlm.nih.gov/pubmed/34198773
http://dx.doi.org/10.3390/cancers13112819

Ejemplares similares